Clinical Trial Update: Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on doxycycline for airway inflammation in chronic obstructive pulmonary disease, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Emphysema

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Medical Center Alkmaar | Conditions: Chronic Obstructive Pulmonary Disease, Inflammation | Phase 4 | Status: UNKNOWN